Publikasi

Delhi cabinet approves Ayushman Bharat coverage for wid...

New Delhi: The Delhi government on Tuesday decided to bring the beneficiaries of...

Alleged NMC norms violation, no stipend to interns, ill...

Hyderabad: The Telangana High Court has taken suo motu cognisance of complaints ...

Chronic Cola Consumption Reduces Key Immune Cells, Anim...

In a study published in Frontiers in Nutrition, researchers examined the long-te...

Lifestyle disorder not a reason to deny Armed Forces di...

New Delhi: The Delhi High Court on Thursday quashed the Armed Forces Tribunal (A...

Ketogenic Diet May Reduce Epileptic Seizures by Changin...

A ketogenic diet-rich in fat and extremely low in carbohydrates-has been used fo...

Zenex Animal Health acquires majority stake in Netherla...

Transaction marks entry into global naturals market and sets up manufacturing a...

Lupin ranked among top 1% globally in S&P Global Corpor...

Company scores 91 out of 100; included in Sustainability Yearbook 2026 for thir...

Tailored orthodontic care without compromise

Discover Clarity Portal’s ability to give you the freedom to choose the best ort...

Elderly homoeopathic doctor living alone rescued by NGO...

Chandigarh: In a disturbing incident in Haryana's Karnal district, an 80-year-ol...

Gleneagles Hospital Mumbai partners with Medtronic to l...

Mumbai: Medtronic, a global leader in healthcare technology, has announced a par...

Glenmark to launch Sodium Phosphates Injection USP sing...

Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million an...

GLP-1 drugs combined with healthy lifestyle habits link...

Individuals living with type 2 diabetes (T2D) had a significantly lower risk of ...

Add on DAPT to Rivaroxaban Fails to Reduce Left Ventric...

France: Researchers have found in a new multicenter randomized clinical trial of...

Maha to mandate health schemes empanelment for all char...

Maharashtra: Maharashtra Chief Minister Devendra Fadnavis on Tuesday informed th...

Mutant p53 Selective Reactivation Demonstrated in Advan...

In Phase I, 77 pretreated patients with advanced solid tumors harboring a TP53 Y...

City Therapeutics Pursues ‘Next Generation of RNAi’

City Therapeutics launched its first clinical program last fall, when it began a...